Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
复制标题
DOI:
10.1371/journal.pbio.3001480
复制
发表时间:
2021-12
期刊:
影响因子:
9.8
通讯作者:
Cookson MR
中科院分区:
文献类型:
--
作者:
Mamais A;Kluss JH;Bonet-Ponce L;Landeck N;Langston RG;Smith N;Beilina A;Kaganovich A;Ghosh MC;Pellegrini L;Kumaran R;Papazoglou I;Heaton GR;Bandopadhyay R;Maio N;Kim C;LaVoie MJ;Gershlick DC;Cookson MR
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal dominant Parkinson disease (PD), while polymorphic LRRK2 variants are associated with sporadic PD. PD-linked mutations increase LRRK2 kinase activity and induce neurotoxicity in vitro and in vivo. The small GTPase Rab8a is a LRRK2 kinase substrate and is involved in receptor-mediated recycling and endocytic trafficking of transferrin, but the effect of PD-linked LRRK2 mutations on the function of Rab8a is poorly understood. Here, we show that gain-of-function mutations in LRRK2 induce sequestration of endogenous Rab8a to lysosomes in overexpression cell models, while pharmacological inhibition of LRRK2 kinase activity reverses this phenotype. Furthermore, we show that LRRK2 mutations drive association of endocytosed transferrin with Rab8a-positive lysosomes. LRRK2 has been nominated as an integral part of cellular responses downstream of proinflammatory signals and is activated in microglia in postmortem PD tissue. Here, we show that iPSC-derived microglia from patients carrying the most common LRRK2 mutation, G2019S, mistraffic transferrin to lysosomes proximal to the nucleus in proinflammatory conditions. Furthermore, G2019S knock-in mice show a significant increase in iron deposition in microglia following intrastriatal LPS injection compared to wild-type mice, accompanied by striatal accumulation of ferritin. Our data support a role of LRRK2 in modulating iron uptake and storage in response to proinflammatory stimuli in microglia. Brain iron deposition is a feature of Parkinson’s disease pathology, but how this contributes to neurodegeneration is unclear. This study show that Parkinson’s disease-linked mutations in LRRK2 cause aberrant brain iron accumulation in vivo and iron dyshomeostasis in vitro, supporting a role of LRRK2 in modulating iron uptake and storage in response to proinflammatory stimuli in microglia.
登录
查看更多内容
影响因子:
2.9
作者:
Faucheux, BA;Hauw, JJ;Hirsch, EC
通讯作者:
Hirsch, EC
影响因子:
4
作者:
Hockey LN;Kilpatrick BS;Eden ER;Lin-Moshier Y;Brailoiu GC;Brailoiu E;Futter CE;Schapira AH;Marchant JS;Patel S
通讯作者:
Patel S
影响因子:
2.9
作者:
Guan X;Xuan M;Gu Q;Huang P;Liu C;Wang N;Xu X;Luo W;Zhang M
通讯作者:
Zhang M
DOI:
10.15252/embj.2020104494
发表时间:
2020-09-15
期刊:
The EMBO journal
影响因子:
--
作者:
Herbst S;Campbell P;Harvey J;Bernard EM;Papayannopoulos V;Wood NW;Morris HR;Gutierrez MG
通讯作者:
Gutierrez MG
DOI:
10.1038/s41531-017-0010-8
发表时间:
2017
期刊:
NPJ Parkinson's disease
影响因子:
--
作者:
Cook DA;Kannarkat GT;Cintron AF;Butkovich LM;Fraser KB;Chang J;Grigoryan N;Factor SA;West AB;Boss JM;Tansey MG
通讯作者:
Tansey MG